BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Morishita A, Oura K, Tadokoro T, Fujita K, Tani J, Masaki T. MicroRNAs in the Pathogenesis of Hepatocellular Carcinoma: A Review. Cancers (Basel) 2021;13:514. [PMID: 33572780 DOI: 10.3390/cancers13030514] [Cited by in Crossref: 6] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Gjorgjieva M, Ay A, Correia de Sousa M, Delangre E, Dolicka D, Sobolewski C, Maeder C, Fournier M, Sempoux C, Foti M. MiR-22 Deficiency Fosters Hepatocellular Carcinoma Development in Fatty Liver. Cells 2022;11:2860. [DOI: 10.3390/cells11182860] [Reference Citation Analysis]
2 Ruiz-manriquez LM, Carrasco-morales O, Sanchez Z EA, Osorio-perez SM, Estrada-meza C, Pathak S, Banerjee A, Bandyopadhyay A, Duttaroy AK, Paul S. MicroRNA-mediated regulation of key signaling pathways in hepatocellular carcinoma: A mechanistic insight. Front Genet 2022;13:910733. [DOI: 10.3389/fgene.2022.910733] [Reference Citation Analysis]
3 Khan S, Zhang D, Zhang J, Hayat MK, Ren J, Nasir S, Fawad M, Bai Q. The Key Role of microRNAs in Initiation and Progression of Hepatocellular Carcinoma. Front Oncol 2022;12:950374. [DOI: 10.3389/fonc.2022.950374] [Reference Citation Analysis]
4 Zabady S, Mahran N, Soltan MA, Alaa Eldeen M, Eid RA, Albogami S, Fayad E, Matboli M, Habib EK, Hasanin AH, A. Ali M, Mesbah NM, Abo-elmatty DM, Abdel-hamed AR. Cyanidin-3-Glucoside Modulates hsa_circ_0001345/miRNA106b/ATG16L1 Axis Expression as a Potential Protective Mechanism against Hepatocellular Carcinoma. CIMB 2022;44:1677-87. [DOI: 10.3390/cimb44040115] [Reference Citation Analysis]
5 El-Mahdy HA, Sallam AM, Ismail A, Elkhawaga SY, Elrebehy MA, Doghish AS. miRNAs inspirations in hepatocellular carcinoma: Detrimental and favorable aspects of key performers. Pathol Res Pract 2022;233:153886. [PMID: 35405621 DOI: 10.1016/j.prp.2022.153886] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Ratnasari N, Lestari P, Renovaldi D, Raditya Ningsih J, Qoriansas N, Wardana T, Hakim S, Signa Aini Gumilas N, Indrarti F, Triwikatmani C, Bayupurnama P, Setyo Heriyanto D, Astuti I, Mubarika Harjana S. Potential plasma biomarkers: miRNA-29c, miRNA-21, and miRNA-155 in clinical progression of Hepatocellular Carcinoma patients. PLoS One 2022;17:e0263298. [PMID: 35157721 DOI: 10.1371/journal.pone.0263298] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Lv HC, Lv YY, Wang G, Zhang XH, Li SN, Yue XF, Lu W. Mechanism of miR-424-5p promoter methylation in promoting epithelial-mesenchymal transition of hepatocellular carcinoma cells. Kaohsiung J Med Sci 2022. [PMID: 35049148 DOI: 10.1002/kjm2.12499] [Reference Citation Analysis]
8 Elghoroury EA, Abdelghaffar EE, Awadallah E, Kamel SA, Kandil D, Hassan EM, Hassan M, Kamel MM, Gomaa MM, Fathalla LA. Detection of exosomal miR-18a and miR-222 levels in Egyptian patients with hepatic cirrhosis and hepatocellular carcinoma. Int J Immunopathol Pharmacol 2022;36:3946320221097832. [PMID: 35467432 DOI: 10.1177/03946320221097832] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Bardhi E, Mcdaniels J, Rousselle T, Maluf DG, Mas VR. Nucleic acid biomarkers to assess graft injury after liver transplantation. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100439] [Reference Citation Analysis]
10 Wang L, Wu J, Ye N, Li F, Zhan H, Chen S, Xu J. Plasma-Derived Exosome MiR-19b Acts as a Diagnostic Marker for Pancreatic Cancer. Front Oncol 2021;11:739111. [PMID: 34589435 DOI: 10.3389/fonc.2021.739111] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
11 Shi T, Morishita A, Kobara H, Masaki T. The Role of Long Non-Coding RNA and microRNA Networks in Hepatocellular Carcinoma and Its Tumor Microenvironment. Int J Mol Sci 2021;22:10630. [PMID: 34638971 DOI: 10.3390/ijms221910630] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Wang Y, Chen X, Li J, Xia C. Quercetin Antagonizes Esophagus Cancer by Modulating miR-1-3p/TAGLN2 Pathway-Dependent Growth and Metastasis. Nutr Cancer 2021;:1-10. [PMID: 34498538 DOI: 10.1080/01635581.2021.1972125] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Tadokoro T, Morishita A, Masaki T. Diagnosis and Therapeutic Management of Liver Fibrosis by MicroRNA. Int J Mol Sci 2021;22:8139. [PMID: 34360904 DOI: 10.3390/ijms22158139] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
14 Shi T, Morishita A, Kobara H, Masaki T. The Role of microRNAs in Cholangiocarcinoma. Int J Mol Sci 2021;22:7627. [PMID: 34299246 DOI: 10.3390/ijms22147627] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
15 Qin S, Xu J, Yi Y, Jiang S, Jin P, Xia X, Ma F. Transcription Factors and Methylation Drive Prognostic miRNA Dysregulation in Hepatocellular Carcinoma. Front Oncol 2021;11:691115. [PMID: 34307154 DOI: 10.3389/fonc.2021.691115] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
16 Gramantieri L, Giovannini C, Piscaglia F, Fornari F. MicroRNAs as Modulators of Tumor Metabolism, Microenvironment, and Immune Response in Hepatocellular Carcinoma. J Hepatocell Carcinoma 2021;8:369-85. [PMID: 34012928 DOI: 10.2147/JHC.S268292] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
17 Fujihara S, Kobara H, Nishiyama N, Hirose K, Iwama H, Masaki T. MicroRNA Expression Profiles in Superficial Esophageal Squamous Cell Carcinoma before Endoscopic Submucosal Dissection: A Pilot Study. Int J Mol Sci 2021;22:4789. [PMID: 33946439 DOI: 10.3390/ijms22094789] [Reference Citation Analysis]